Form 4: Concentra Director Pegus Granted 7,748 Restricted Shares

Concentra Group Holdings Parent, Inc. Director Cheryl Pegus received a grant of 7,748 shares of restricted common stock, which will vest in full on November 4, 2026.

Summary

• Cheryl Pegus, a Director of Concentra Group Holdings Parent, Inc. (CON), was granted 7,748 shares of common stock.
• The transaction occurred on November 4, 2025.
• The granted shares are restricted stock and will vest in full on November 4, 2026.
• Following this transaction, Ms. Pegus beneficially owns 20,740 shares of common stock.
• The acquisition price for these shares was $0, which is typical for a restricted stock grant.

Sentiment

Score: 6

Explanation: Slightly positive. A routine insider stock grant aligns director interests with shareholders, which is generally viewed favorably, though it's not a significant market-moving event on its own.

Positives

• The grant of restricted stock to Director Cheryl Pegus aligns her interests with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• The vesting schedule provides an incentive for long-term commitment and performance from the director.

Negatives

• No negative aspects are indicated in this routine insider transaction filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

The 7,748 shares of restricted stock granted to Director Cheryl Pegus are scheduled to vest in full on November 4, 2026, subject to certain exceptions.

Industry Context

This Form 4 filing is a standard disclosure for insider transactions, reflecting equity compensation practices common across publicly traded companies to align management and director interests with shareholder value creation. Such grants are a routine part of executive and director compensation packages in the healthcare services industry, where Concentra operates.

Comparison to Industry Standards

• The grant of restricted stock to a director is a common practice in corporate governance across various industries, including healthcare services. It aligns with typical compensation structures designed to incentivize long-term performance and retention.
• While specific grant sizes vary by company, market capitalization, and individual roles, the mechanism itself is a standard benchmark for insider equity compensation.

Related Party Transactions

• The grant of restricted stock to Director Cheryl Pegus is a related party transaction, as it involves an insider of the company.

Stakeholder Impact

• Shareholders: The grant of restricted stock to a director can be seen as positive for shareholders, as it aligns the director's financial interests with the long-term performance of the company's stock.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The restricted stock granted to Cheryl Pegus will vest on November 4, 2026.

Key Dates

Keywords

Concentra Group Holdings Parent Inc, CON, Cheryl Pegus, Director, Restricted Stock Grant, Insider Transaction, Form 4, Equity Compensation, Stock Vesting